维普中文期刊产品整合服务
109篇 您的检索式:作者名="Eren N"
    题名 作者 年代 出处 被引量
1Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension显示文摘AIM:Adrenomedullin (ADM) is a potent vasodilator peptide.ADM and nitric oxide (NO) are produced in vascular endothelial cells. Increased ADM level has been linked to hyperdynamic circulation and arterial vasodilatation in cirrhotic portal hypertension (CPH). The role of ADM in non-cirrhotic portal hypertension (NCPH) is unknown, plasma ADM levels were studied in patients with NCPH, compensated and decompensated cirrhosis in order to determine its contribution to portal hypertension (PH) in these groups.METHODS: There were 4 groups of subjects. Group 1consisted of 27 patients (F/M: 12/15) with NCPH due to portal and/or splenic vein thrombosis (mean age: 41±12years), group 2 consisted of 14 patients (F/M: 6/8) with compensated (Child-Pugh A) cirrhosis (mean age: 46±4),group 3 consisted of 16 patients (F/M: 6/10) with decompensated (Child-Pugh C) cirrhosis (mean age: 47±12).Fourteen healthy subjects (F/M: 6/8) (mean age: 44±8) were used as controls in Group 4. ADM level was measured by ELISA. NO was determined as nitrite/nitrate level by chemoluminescence.RESULTS: Adl level in Group 11 (236±61.4 pg/mL) was significantly higher than that in group 2 (108.4±28.3 pg/mL)and group 4 (84.1±31.5 pg/mL) (both P<0.0001) but was lower than that in Group3 (324±93.7 pg/mL) (P=0.002). NO level in group 1 (27±1.4 μmol/L) was significantly higher than that in group 2 (19.8±2.8 μmol/L) and group 4 (16.9±1.6μmol/L) but was lower than that in Group 3 (39±3.6 μmol/L)(for all three P<0.0001). A strong correlation was observed between ADM and NO levels (r=0.827, P<0.0001).CONCLUSION: Adrenomedullin and NO levels were high in both non-cirrhotic and cirrhotic portal hypertension and were closely correlated, Adrenomedullin and NO levels increased proportionally with the severity of cirrhosis, and were significantly higher than those in patients with NCPH.Portal hypertension plays an important role in the increase of ADM and NO. Parenchymal damage in cirrhosis may contribute to the increase in these parameters.V Tahan E Avsar C Karaca E Uslu F Eren S Aydin H Uzun HO Hamzaoglu F Besisik C Kalayci A Okten N Tozun 2003World Journal of Gastroenterology2003,9,10:5
2Vascular injuries and amputation following limb fractures 显示文摘EREN N OZGEN G GUREL A 1990Thorac Cardiovasc Surg1990,38,:1
3The determinants of right ventricular function in patients with atrial septal defect显示文摘Gorgulu S Eren M Uslu N 2006Int J Cardiol2006,111,:1
4Sudden death related to anomalous origin of coronary artery and coexisting fenestrated membrane of the sinus coronaries显示文摘Türkmen N Eren B Fedakar R 2007Singapore Med J2007,48,7:1
5Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major显示文摘Eren E Yilmaz N 0,,01:1
6Diagnostic value of C -reactive protein in patients with angiographically documentedcoronary heart disease 显示文摘Eren E Yilmaz N Pence S 2002Aeta Medic(Hradec Kralove)2002,45,4:1
7Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management显示文摘Askin Ender Topal Y Celik N Eren 2010Vascular Health and Risk Management (default)2010,,:1
8Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection 显示文摘Dinleyici EC Eren M Dogan N 2011Parasitol Res2011,108,3:1
9Removal of Cu ( Ⅱ ) ions by activated poplar sawdust ( Samsun Clone) from aqueous solutions 显示文摘Acar F N Eren Z 2006Journal of Hazardous Materials2006,137,:1
10Quantum-chemical, IR, NMR, and X-ray diffraction studies on 2-( 4-chloro?phenyl)-l-methyl-lH-benzo显示文摘Ozdemir N Eren B Dincer M 2011IntJ Quantum Chem2011,111,12:1
11Oxidative stress and ischemi- a-modified albumin in chronic ischemic heart failure 显示文摘Ellidag HY Eren E Yilmaz N 2014Redox Rep2014,19,3:1
12Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease显示文摘 Yilmaz N Pence S 2002Acta Medica (Hradec Kralove)2002,45,4:1
13Effects of N-acetylcysteine on pul- monary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass显示文摘Eren N Cakir O Oruc A 2003Perfusion2003,18,6:1
14直接前方入路全髋置换术的临床应用趋势显示文摘为研究直接前方入路(DAA)全髋置换术的临床应用趋势,作者进行了一项电子邮件调查,对象是美国髋膝关节协会会员医生,分析DAA全髋置换术的临床预期效果和经济效益。996位医生给予了回复,占美国髋膝关节协会会员医生44.3%,其中56.2%的医生做DAA全髋置换术。做DAA全髋置换术医生比不做DAA全髋置换术医生执业年限短(分别为17年和20.9年);同样,做DAA全髋置换术比较多的医生比做DAA全髋置换术少的医生执业年限短。做DAA全髋置换术的医生认为翻修术、解剖复杂以及身体状况是改行后路全髋置换术的常见原因。不做DAA全髋置换术医生认为DAA全髋置换效果不佳、无临床益处以及学习曲线长。Patel N N Shah J A Erens G A 胡孔足 2019临床骨科杂志2019,22,3:1
15Clinical evaluation(Phase I)of a human monoclonal antibody against hepatitis Cvirus:Safety and antiviral activity显示文摘Galun E Terrault N A Eren R 2007J Hepatol2007,46,:1
16Surgical Treatment of Post-Traumatic Tracheobronchial Injuries: 14-year experience 显示文摘Balci AE Eren N Eren S 2002European Journal of Cardiothoracic Surgery2002,22,6:1
17Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease 显示文摘Eren E Yilmaz N Pence S 2002Acta Medica ( Hradec kralove)2002,,4:1
18Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease显示文摘Eren E Yilmaz N Pence S et a 2002Acta Medica( Hradec kralove )2002,,4:1
19Diag- nostic value of C-reactive protein in pati- ents with angiographically documented coronary heart disease显示文摘Eren E Yilmaz N Pence S 2002Acta Medic (Hradec Kralove)2002,45,4:1
20Facile and green fabrication of silver nanoparticles on a polyoxometalate for Li-ion battery显示文摘EREN T ATAR N YOLA M L 2015Ionics2015,9,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费